Elizabeth Czerepak

Insider Reports History

Entity
Individual
Location
201 Route 17 North, Rutherford, NJ
Signature
/s/ Gerard Michel, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Elizabeth Czerepak:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Scilex Holding Co Executive Vice President, Chief Business Officer and Chief Financial Officer Nonstatutory Stock Option (right to buy) 350K Jan 17, 2023 Direct
Sorrento Therapeutics, Inc. EVP & Chief Financial Officer Stock Option (right to buy) 350K May 18, 2022 Direct
DELCATH SYSTEMS, INC. Director Stock Option (right to buy) 22.5K May 23, 2024 Direct

Insider Reports Filed by Elizabeth Czerepak

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DCTH DELCATH SYSTEMS, INC. May 23, 2024 1 $0 4 May 28, 2024 Director
DCTH DELCATH SYSTEMS, INC. Jun 12, 2023 1 $0 4 Jun 21, 2023 Director
SCLX Scilex Holding Co Jan 17, 2023 1 $0 4 Jan 17, 2023 Executive Vice President, Chief Business Officer and Chief Financial Officer
SCLX Vickers Vantage Corp. I Nov 10, 2022 0 $0 3 Nov 15, 2022 Officer
SRNEQ Sorrento Therapeutics, Inc. May 18, 2022 1 $0 4 May 20, 2022 EVP & Chief Financial Officer
DCTH DELCATH SYSTEMS, INC. May 4, 2022 1 $0 4 May 6, 2022 Director
SRNEQ Sorrento Therapeutics, Inc. Nov 18, 2021 1 $0 4 Nov 18, 2021 Director
SRNEQ Sorrento Therapeutics, Inc. Nov 15, 2021 0 $0 3 Nov 18, 2021 Director
DCTH DELCATH SYSTEMS, INC. Aug 5, 2021 1 $0 4 Aug 9, 2021 Director